Sun Pharma Advanced Research Company Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

75.55

238.78

137.25

252.96

76.82

Operating profit

-403.79

-214.06

-186.75

-134.98

-310.01

Interest

1.66

7.63

13.33

10.65

2.67

Gross profit

-375.98

-210.81

-193.24

-140.22

-302.92

EPS (Rs)

-11.96

-6.86

-7.48

-5.77

-11.92

Other income

29.47

10.88

6.84

5.41

9.76

Stock adjustment

-

-

-

-

-

Raw material

28.13

22.11

18.27

18.18

23.92

Power and fuel

-

-

-

-

-

Employee expenses

118.53

106.99

96.78

91.58

93.09

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

332.68

323.74

208.95

278.18

269.82

Provisions made

-

-

-

-

-

Depreciation

12.13

11.77

10.16

10.92

9.48

Taxation

-

-

-

-

-

Net profit / loss

-388.11

-222.58

-203.40

-151.14

-312.40

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

32.45

32.45

27.19

26.21

26.21

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-534.47

-89.65

-136.07

-53.36

-403.55

GPM (%)

-358.01

-84.44

-134.11

-54.27

-349.87

NPM (%)

-369.56

-89.15

-141.16

-58.50

-360.82